Stem cell technologies market to hit $700M in 2012
NEW YORK CITY – The market for stem cell technologies will rise to over $700 million this year, and given some positive trends, could reach over $1 billion, according to healthcare market research publisher Kalorama Information.
In its new report, “Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development,” Kalorama cites newly permitted U.S. usage and accompanying research funding in its positive forecasts.
Kalorama included a range for its market forecast because some factors are variable.
